Alcohol and benzodiazepine (BZD) withdrawal are clinical manifestations of the abrupt cessation or reduction in the use of substances which have been used regularly and heavily. Larger quantities and longer durations are associated with greater risk of developing significant alcohol or BZD withdrawal, which can be a medical emergency. Goals of treatment include minimizing and/or preventing the symptoms of withdrawal with a focus on prevention of seizures and delirium tremens (DTs).
The toolkit provides information in the following areas:
Authored by AAPP member Zoe Karavolis, PharmD, BCPP, this toolkit is intended to highlight both the evidence base available as well as strategies of clinical decision making used by expert clinicians.
